Skip to main content

Elena Andretta

Institutions of which they are part

Research technician
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Elena Andretta

Institutions of which they are part

Research technician
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Projects

Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders

IP: Lucas Moreno Martín-Retortillo
Collaborators: Luís Gros Subias, Raquel Andreu Vilarroig, Andrea Vilaplana Blanes, Pablo Velasco Puyó, Laura Murillo Sanjuán, Maria Isabel Benitez Carabante, Aroa Soriano Fernández, Guillem Pons Barcons, Jose Miguel Lizcano De Vega, Maria Cristina Díaz de Heredia Rubio, Maria Luz Uría Oficialdegui, Maria Jose Pérez García, Miguel Segura Ginard, M Mar Mañu Pereira, Lorena Valero Arrese, Thaïs Murciano Carrillo, Constantino Sábado Álvarez, Anna Llort Sales, Elisabet Megías Roda, Raquel Hladun Alvaro, Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders, Carlota Aguilera Ordoñez, Adria Molero Valenzuela, Júlia Sansa Girona, Gabriela Guillén Burrieza, Laura Alonso Garcia, Victoria Gutierrez Valle, Idoia Bolinaga Ayala, Josep Roma Castanyer, Sergio Espinosa Gil, Elena Andretta, Claire Diot, Amira Idrizovic
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00638
Duration: 01/01/2022 - 30/06/2025

RHOA signaling in gastric cancer: friend or foe?

IP: -
Collaborators: Nivardo Rodríguez Conde, Manuel Armengol Carrasco, Stefania Landolfi , Elena Andretta
Funding agency: Asociación Española Contra el Cáncer
Funding: 1015000
Reference: 2015/AECC-GCE/ARANGO
Duration: 01/07/2015 - 30/06/2022

Oncologia Molecular (GRC)

IP: -
Collaborators: Elena Andretta
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014 SGR 1084
Duration: 01/01/2014 - 31/12/2016

Maintenance of the epithelial brush border and colateral cancer

IP: -
Collaborators: Elena Andretta
Funding agency: Instituto de Salud Carlos III
Funding: 324885
Reference: PI12/01095
Duration: 01/01/2013 - 30/06/2017

Related news

A study jointly led by the Hospital Clínic of Barcelona and the Vall d'Hebron Research Institute (VHIR) confirms the effectiveness of neonatal screening in reducing morbidity among children with sickle cell disease (SCD).

Active participation by patients and families in studies helps identify more effective therapies that improve quality of life and survival.

The funds will strengthen research lines focused on nervous system tumors.

Related professionals

Marta Sanchiz Cruz

Marta Sanchiz Cruz

Research technician
Infectious Diseases
Read more
M. Mercè Fabregat  Bosch

M. Mercè Fabregat Bosch

Reconstructive Surgery of the Locomotor System
Read more
Jordi Giralt López de Sagred

Jordi Giralt López de Sagred

Read more
Angel Manuel Lorente Cobo

Angel Manuel Lorente Cobo

Auxiliar Tècnic/a Recerca
Experimental Surgery Unit (ESU)
Preclinical Core Facilities
External Strategy Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.